- Previous Close
14.50 - Open
14.50 - Bid 14.10 x --
- Ask 14.20 x --
- Day's Range
14.00 - 14.50 - 52 Week Range
13.40 - 21.60 - Volume
3,872,665 - Avg. Volume
6,112,739 - Market Cap (intraday)
35.415B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
27.84 - EPS (TTM)
0.51 - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield 0.40 (2.82%)
- Ex-Dividend Date May 2, 2025
- 1y Target Est
19.07
Bangkok Chain Hospital Public Company Limited, together with its subsidiaries, operates private hospitals in Bangkok vicinity, Chiang Rai, Saraburi, Nonthaburi, Pathumthani, Ayudhaya, Chachoengsao, Prachinburi, Sa Kaeo Province, and Lao People's Democratic Republic. It offers diagnosis, treatment, prevention, rehabilitation services for heart disease; open heart surgery to provide heart care and clinical treatment by cardiologists; and medical supports. The company also operates diagnostic imaging centers; eye centers that provide eye examination, treatment, and surgery services; cancer centers that offer services ranging from screening, diagnosis, and chemotherapy; fertility centers for infertility treatment, as well as diabetic wound treatment centers. In addition, the company sells health-related drinks; provides medical analysis and research services; and develops package computer programs. The company was founded in 1984 and is headquartered in Nonthaburi, Thailand.
www.bangkokchainhospital.com/th/home--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BCH.BK
View MorePerformance Overview: BCH.BK
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BCH.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BCH.BK
View MoreValuation Measures
Market Cap
35.41B
Enterprise Value
34.93B
Trailing P/E
27.84
Forward P/E
22.17
PEG Ratio (5yr expected)
2.18
Price/Sales (ttm)
3.00
Price/Book (mrq)
2.73
Enterprise Value/Revenue
2.96
Enterprise Value/EBITDA
12.46
Financial Highlights
Profitability and Income Statement
Profit Margin
10.84%
Return on Assets (ttm)
6.09%
Return on Equity (ttm)
10.14%
Revenue (ttm)
11.83B
Net Income Avi to Common (ttm)
1.28B
Diluted EPS (ttm)
0.51
Balance Sheet and Cash Flow
Total Cash (mrq)
1.35B
Total Debt/Equity (mrq)
6.40%
Levered Free Cash Flow (ttm)
628.74M